Russia's Pharmasyntez ready to ship 1 mln packs of remdesivir to India
- Country:
- Russia
Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir COVID-19 treatment to India by the end of May, once it receives approval from the Russian government.
In comments to Reuters, the Russian drugmaker said it was waiting for a legal basis on which it could send the shipment of the generic version it produces of the U.S. COVID-19 drug remdesivir, used to treat U.S. President Donald Trump.
ALSO READ
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
Cleaner Kitchens, Polluted Skies: Hidden Health Cost of India’s Electricity Boom
-
Japan-Backed ILO Projects Help 23,000 Workers Gain Rights and Fight Child Labour
-
Screwworm Resurgence Threatens U.S.-Mexico Livestock Trade
Google News